Drug Trial Radar · NCT04040192
A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis
Last checked: Nov 20, 2026Latest source record: Mar 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
620
Actual
Start
Sep 12, 2019
Primary completion
Jan 19, 2022
Study completion Jan 19, 2022
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jul 31, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate crisaborole therapy once daily (QD) as a long-term topical maintenance therapy for the reduction of flare in responders to crisaborole twice daily (BID) treatment.
Conditions
- Atopic Dermatitis
Interventions
Crisaborole 2%Drug
Crisaborole ointment 2%
VehicleDrug
Vehicle ointment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Duration of Flare-Free Maintenance Until Onset of First-Flare During the Double Blind (DB) PeriodTime frame: From randomization to first flare or last ISGA assessment (up to 52 weeks)
- Number of Participants With Treatment Emergent Adverse Events (TEAEs)Time frame: Crisaborole 2% BID: From start of study intervention in OL period up to 8 weeks ; Vehicle QD and crisaborole 2% QD: From start of study intervention in DB period up to 28 days after last dose of study intervention (maximum of 56 weeks)
Locations
44 sites in 6 countries. Site status is shown where the registry gives one.
First OC Dermatology
Fountain Valley, California
Center for Dermatology Clinical Research, Inc.
Fremont, California
Asthma and Allergy Associates, PC
Colorado Springs, Colorado
Colorado Springs Dermatology Clinic, PC
Colorado Springs, Colorado
Skin Care Research LLC
Boca Raton, Florida
Clinical Neuroscience Solutions, Inc
Jacksonville, Florida
Olympian Clinical Research
Largo, Florida
Baumann Cosmetic and Research Institute
Miami, Florida
Clinical Neuroscience Solutions, Inc
Orlando, Florida
The Indiana Clinical Trials Center, PC
Plainfield, Indiana
Meridian Clinical Research, LLC
Baton Rouge, Louisiana
Great Lakes Research Group, Inc.
Bay City, Michigan
Skin Specialists PC
Omaha, Nebraska
Ohio Pediatric Research Association, Inc.
Dayton, Ohio
Lynn Health Science Institute
Oklahoma City, Oklahoma
Oklahoma State University - Center for Health Sciences
Tulsa, Oklahoma
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee
Innovate Research, LLC
Fort Worth, Texas
Austin Institute for Clinical Research
Houston, Texas
Austin Institute for Clinical Research, Inc.
Pflugerville, Texas
Center for Clinical Studies, LTD. LLP
Webster, Texas
Jordan Valley Dermatology Center
South Jordan, Utah
PI-Coor Clinical Research LLC
Burke, Virginia
Dermatology Specialists of Spokane
Spokane, Washington
Principle Research Solutions
Spokane, Washington
Australian Clinical Research Network
Maroubra, New South Wales, Australia
SimcoDerm Medical and Surgical Dermatology Center
Barrie, Ontario, Canada
Milestone Research , Inc
London, Ontario, Canada
North York Research Inc.
North York, Ontario, Canada
Manna Research Toronto
Toronto, Ontario, Canada
Skinsense Medical Research
Saskatoon, Saskatchewan, Canada
Peking University First Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Dermatology Hospital of Jiangxi Province
Nanchang, Jiangxi, China
Huashan Hospital Fudan University/Dermatology Department
Shanghai, Shanghai Municipality, China
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Hangzhou Third Hospital
Hangzhou, Zhejiang, China
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.